| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,105 |
3,829 |
$1.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,984 |
9,429 |
$738K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,775 |
15,028 |
$680K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,914 |
3,783 |
$448K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,596 |
3,397 |
$176K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,676 |
2,605 |
$105K |
| 80053 |
Comprehensive metabolic panel |
7,271 |
6,734 |
$84K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,725 |
8,089 |
$82K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,351 |
2,270 |
$80K |
| 87634 |
|
717 |
701 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
584 |
570 |
$32K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,120 |
2,005 |
$31K |
| 87070 |
|
2,278 |
2,152 |
$25K |
| 83690 |
|
1,965 |
1,831 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
1,175 |
1,115 |
$13K |
| 81001 |
|
3,023 |
2,841 |
$13K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
91 |
76 |
$12K |
| 81025 |
|
2,928 |
2,741 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
37 |
37 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
630 |
570 |
$7K |
| 85610 |
|
1,557 |
1,448 |
$7K |
| 84484 |
|
466 |
421 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
615 |
585 |
$5K |
| 83735 |
|
577 |
537 |
$4K |
| 85730 |
|
1,479 |
1,384 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
176 |
171 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
15 |
15 |
$2K |
| 87420 |
|
116 |
112 |
$2K |
| 81003 |
|
673 |
619 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
30 |
25 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
153 |
143 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
14 |
13 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
30 |
29 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
921 |
866 |
$973.80 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
173 |
105 |
$618.88 |
| 86617 |
|
13 |
13 |
$593.58 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
102 |
92 |
$332.91 |
| 85018 |
|
97 |
93 |
$315.77 |
| 85014 |
|
97 |
93 |
$315.77 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
873 |
798 |
$238.10 |
| 87147 |
|
28 |
25 |
$230.46 |
| 83655 |
|
12 |
12 |
$201.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
188 |
184 |
$197.52 |
| 74018 |
|
14 |
14 |
$158.76 |
| 85027 |
|
120 |
102 |
$148.43 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$148.28 |
| 80076 |
|
60 |
53 |
$108.68 |
| 85652 |
|
27 |
27 |
$107.19 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
59 |
54 |
$83.70 |
| 82150 |
|
41 |
36 |
$72.63 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
40 |
30 |
$51.36 |
| J2704 |
Injection, propofol, 10 mg |
162 |
145 |
$32.87 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
440 |
201 |
$24.86 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
57 |
49 |
$10.39 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
630 |
564 |
$2.61 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
112 |
89 |
$2.26 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
87 |
82 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
203 |
193 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
277 |
251 |
$0.00 |
| A9270 |
Non-covered item or service |
760 |
693 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
17 |
13 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
148 |
134 |
$0.00 |
| 88312 |
|
16 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
28 |
27 |
$0.00 |